Intra-Arterial Microdosing: Proof-of-Concept in Humans
NCT02304211
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Insulin
Sponsor
Duke University